Given the complex interplay between IL‐33 signaling, cellular senescence, and DN pathogenesis, it is crucial to explore how modulating IL‐33 could influence senescence and disease outcomes.20, 21. This evidence concerns the gene IL33 and liver dysplastic nodule.